IKKi Deficiency Promotes Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Dai, Jia ^a,b   Shen, Di Fei ^a,b   Bian, Zhou Yan ^a,b   Zhou, Heng ^a,b   Gan, Hua Wen ^a,b   Zong, Jing ^a,b   Deng, Wei ^a,b   Yuan, Yuan ^a,b   Li, FangFang ^a,b   Wu, Qing Qing ^a,b   Gao, Lu ^c   Zhang, Rui ^a,b   Ma, Zhen Guo ^a,b   Li, Hong Liang ^a,b   Tang, Qi Zhu ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; AORTA BANDING; APOPTOSIS; ARTERY SURGERY; ARTICLE; CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; ECHOCARDIOGRAPHY; ENZYME ACTIVATION; ENZYME DEFICIENCY; ENZYME INHIBITION; GENE OVEREXPRESSION; HEART FUNCTION; HEART HEMODYNAMICS; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; APOPTOSIS; CARDIOMEGALY; FIBROSIS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKOUT TECHNIQUES; GLYCOGEN SYNTHASE KINASE 3; HEART; HEMODYNAMICS; I-KAPPA B KINASE; MALE; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

MUS;

EID: 84872792376     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053412     Document Type: Article

References (38)

1. Tamargo J, Lopez-Sendon J, (2011) Novel therapeutic targets for the treatment of heart failure. Nat Rev Drug Discov 10: 536-555.
2. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, et al. (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10: 933-989.
3. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, et al. (2009) 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: e1-e90.
4. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al. (2010) Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121: 948-954.
5. Pazos-Lopez P, Peteiro-Vazquez J, Carcia-Campos A, Garcia-Bueno L, de Torres JP, et al. (2011) The causes, consequences, and treatment of left or right heart failure. Vasc Health Risk Manag 7: 237-254.
6. Iemitsu M, Miyauchi T, Maeda S, Sakai S, Kobayashi T, et al. (2001) Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat. Am J Physiol Regul Integr Comp Physiol 281: R2029-R2036.
7. De Boer RA, Pinto YM, Van Veldhuisen DJ, (2003) The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities. Microcirculation 10: 113-126.
8. Olson EN, (2004) A decade of discoveries in cardiac biology. Nat Med 10: 467-474.
9. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, et al. (2007) MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116: 258-267.
10. Heineke J, Molkentin JD, (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7: 589-600.
11. Hayden MS, Ghosh S, (2008) Shared principles in NF-kappaB signaling. Cell 132: 344-362.
12. Shih VF, Tsui R, Caldwell A, Hoffmann A, (2011) A single NFkappaB system for both canonical and non-canonical signaling. Cell Res 21: 86-102.
13. Zelarayan L, Renger A, Noack C, Zafiriou MP, Gehrke C, et al. (2009) NF-kappaB activation is required for adaptive cardiac hypertrophy. Cardiovasc Res 84: 416-424.
14. Hirotani S, Otsu K, Nishida K, Higuchi Y, Morita T, et al. (2002) Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 105: 509-515.
15. Higuchi Y, Otsu K, Nishida K, Hirotani S, Nakayama H, et al. (2002) Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy. J Mol Cell Cardiol 34: 233-240.
16. Liu Q, Chen Y, Auger-Messier M, Molkentin JD, (2012) Interaction between NFkappaB and NFAT coordinates cardiac hypertrophy and pathological remodeling. Circ Res 110: 1077-1086.
17. Gaspar-Pereira S, Fullard N, Townsend PA, Banks PS, Ellis EL, et al. (2012) The NF-kappaB subunit c-Rel stimulates cardiac hypertrophy and fibrosis. Am J Pathol 180: 929-939.
18. Hikoso S, Yamaguchi O, Nakano Y, Takeda T, Omiya S, et al. (2009) The I{kappa}B kinase {beta}/nuclear factor {kappa}B signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression. Circ Res 105: 70-79.
19. Wang N, Ahmed S, Haqqi TM, (2005) Genomic structure and functional characterization of the promoter region of human IkappaB kinase-related kinase IKKi/IKKvarepsilon gene. Gene 353: 118-133.
20. Koop A, Lepenies I, Braum O, Davarnia P, Scherer G, et al. (2011) Novel splice variants of human IKKepsilon negatively regulate IKKepsilon-induced IRF3 and NF-kB activation. Eur J Immunol 41: 224-234.
21. Kravchenko VV, Mathison JC, Schwamborn K, Mercurio F, Ulevitch RJ, (2003) IKKi/IKKepsilon plays a key role in integrating signals induced by pro-inflammatory stimuli. J Biol Chem 278: 26612-26619.
22. Shembade N, Harhaj EW, (2011) IKKi: a novel regulator of Act1, IL-17 signaling and pulmonary inflammation. Cell Mol Immunol 8: 447-449.
23. Bulek K, Liu C, Swaidani S, Wang L, Page RC, et al. (2011) The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation. Nat Immunol 12: 844-852.
24. Peant B, Forest V, Trudeau V, Latour M, Mes-Masson AM, et al. (2011) IkappaB-Kinase-epsilon (IKKepsilon/IKKi/IkappaBKepsilon) expression and localization in prostate cancer tissues. Prostate 71: 1131-1138.
25. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, et al. (2003) IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4: 491-496.
26. Peters RT, Liao SM, Maniatis T, (2000) IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex. Mol Cell 5: 513-522.
27. Li H, He C, Feng J, Zhang Y, Tang Q, et al. (2010) Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload. Proc Natl Acad Sci U S A 107: 13818-13823.
28. Sambandam N, Steinmetz M, Chu A, Altarejos JY, Dyck JR, et al. (2004) Malonyl-CoA decarboxylase (MCD) is differentially regulated in subcellular compartments by 5′AMP-activated protein kinase (AMPK). Studies using H9c2 cells overexpressing MCD and AMPK by adenoviral gene transfer technique. Eur J Biochem 271: 2831-2840.
29. Bian ZY, Wei X, Deng S, Tang QZ, Feng J, et al. (2012) Disruption of mindin exacerbates cardiac hypertrophy and fibrosis. J Mol Med (Berl).
30. Zhou H, Shen DF, Bian ZY, Zong J, Deng W, et al. (2011) Activating transcription factor 3 deficiency promotes cardiac hypertrophy, dysfunction, and fibrosis induced by pressure overload. PLoS One 6: e26744.
31. Yan L, Wei X, Tang QZ, Feng J, Zhang Y, et al. (2011) Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3beta and TGF-beta1-Smad signalling. Cardiovasc Res 92: 85-94.
32. Sun HZ, Yang TW, Zang WJ, Wu SF, (2010) Dehydroepiandrosterone-induced proliferation of prostatic epithelial cell is mediated by NFKB via PI3K/AKT signaling pathway. J Endocrinol 204: 311-318.
33. Higuchi Y, Chan TO, Brown MA, Zhang J, DeGeorge BJ, et al. (2006) Cardioprotection afforded by NF-kappaB ablation is associated with activation of Akt in mice overexpressing TNF-alpha. Am J Physiol Heart Circ Physiol 290: H590-H598.
34. Chau TL, Gioia R, Gatot JS, Patrascu F, Carpentier I, et al. (2008) Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated? Trends Biochem Sci 33: 171-180.
35. Joung SM, Park ZY, Rani S, Takeuchi O, Akira S, et al. (2011) Akt contributes to activation of the TRIF-dependent signaling pathways of TLRs by interacting with TANK-binding kinase 1. J Immunol 186: 499-507.
36. Manabe I, Shindo T, Nagai R, (2002) Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 91: 1103-1113.
37. Yamazaki T, Yamashita N, Izumi Y, Nakamura Y, Shiota M, et al. (2012) The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice. Hypertens Res 35: 34-40.
38. Anilkumar N, Sirker A, Shah AM, (2009) Redox sensitive signaling pathways in cardiac remodeling, hypertrophy and failure. Front Biosci 14: 3168-3187.